loadpatents
name:-0.016296148300171
name:-0.013651847839355
name:-0.007343053817749
Chobanian; Harry R. Patent Filings

Chobanian; Harry R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chobanian; Harry R..The latest application filed is for "2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors".

Company Profile
6.12.17
  • Chobanian; Harry R. - Westfield NJ
  • Chobanian; Harry R. - Aberdeen NJ
  • CHOBANIAN; Harry R. - Kenilworth NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors
App 20220289710 - Arasappan; Ashok ;   et al.
2022-09-15
2-amino-n-heteroaryl-nicotinamides as Na.sub.v1.8 inhibitors
Grant 11,377,438 - Arasappan , et al. July 5, 2
2022-07-05
Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
Grant 11,332,463 - Crowley , et al. May 17, 2
2022-05-17
2-amino-n-phenyl-nicotinamides As Nav1.8 Inhibitors
App 20220119363 - Breslin; Michael J. ;   et al.
2022-04-21
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors
App 20210387966 - Arasappan; Ashok ;   et al.
2021-12-16
Antidiabetic heterocyclic compounds
Grant 11,072,602 - Miller , et al. July 27, 2
2021-07-27
Antidiabetic spirochroman compounds
Grant 10,968,232 - Miller , et al. April 6, 2
2021-04-06
Spiropiperidine Allosteric Modulators Of Nicotinic Acetylcholine Receptors
App 20210070745 - Crowley; Brendan M. ;   et al.
2021-03-11
Antidiabetic bicyclic compounds
Grant 10,676,458 - Miller , et al.
2020-06-09
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors
App 20200140411 - Arasappan; Ashok ;   et al.
2020-05-07
Antidiabetic Heterocyclic Compounds
App 20190367495 - Miller; Michael ;   et al.
2019-12-05
Antidiabetic Spirochroman Compounds
App 20190337961 - Miller; Michael ;   et al.
2019-11-07
Antidiabetic Bicyclic Compounds
App 20190071412 - Miller; Michael ;   et al.
2019-03-07
Antidiabetic bicyclic compounds
Grant 9,957,219 - Bara , et al. May 1, 2
2018-05-01
Antidiabetic bicyclic compounds
Grant 9,840,512 - Brockunier , et al. December 12, 2
2017-12-12
Inhibitors Of The Renal Outer Medullary Potassium Channel
App 20170275302 - Pasternak; Alexander ;   et al.
2017-09-28
Antidiabetic Bicyclic Compounds
App 20160280626 - Bara; Thomas ;   et al.
2016-09-29
Antidiabetic Bicyclic Compounds
App 20160002255 - Brockunier; Linda L. ;   et al.
2016-01-07
Inhibitors of the Renal Outer Medullary Potassium channel
Grant 9,139,585 - Walsh , et al. September 22, 2
2015-09-22
Inhibitors of the renal outer medullary potassium channel
Grant 8,999,991 - Tang , et al. April 7, 2
2015-04-07
Inhibitors Of The Renal Outer Medullary Potassium Channel
App 20140309213 - Walsh; Shawn P. ;   et al.
2014-10-16
Inhibitors of the Renal Outer Medullary Potassium Channel
App 20140288088 - Tang; Haifeng ;   et al.
2014-09-25
Pharmaceutical Compositions For The Treatment Of Pain And Other Indications
App 20130030000 - Chobanian; Harry R. ;   et al.
2013-01-31
Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
Grant 8,153,626 - Baker , et al. April 10, 2
2012-04-10
Substituted Diazepine Sulfonamides As Bombesin Receptor Subtype-1 Modulators
App 20100317645 - Baker; Robert K. ;   et al.
2010-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed